Natural Immunogenics Celebrates 20th Anniversary of Breakthrough Silver Hydrosol Technology
December 11, 2018 12:24 ET
|
Natural Immunogenics Corp.
SARASOTA, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Stephen L. Quinto may not have been born with a silver spoon in his mouth, but his breakthrough discovery has advanced colloidal silver technology...
Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System
October 25, 2018 08:30 ET
|
Fluidigm Corporation
Providing the largest source of standardized, multi-omic immune data from healthy human subjects to accelerate translational research SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) --...
ETST Launches Cannabis Therapeutics Website, Shares Updates on their CBD-Based Nutraceutical Patents, & Hints on New Products Launching May 2017
April 20, 2017 07:55 ET
|
Earth Science Tech, Inc.
Hollywood, April 20, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST), an innovative biotech company focused on cannabis (industrial hemp), cannabinoid research and development,...
ETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.
March 06, 2017 07:45 ET
|
Earth Science Tech, Inc.
Hollywood, March 06, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and...
Earth Science Tech Completes New Scientific Formulation of its All Natural Bioceutical Line and Introduces Cutting-Edge Advanced Hemp CBD (Cannabidiol) Stacking Systems for Health and Well-Being
January 07, 2016 08:00 ET
|
Earth Science Tech, Inc.
Boca Raton, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Bioceuticals are the nutritional building blocks necessary for making new DNA and RNA, which have to be obtained from our diets,...
Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors
December 16, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today further progress on developing Ampligen® (rintatolimod)...
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26
June 25, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, June 25, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), will present a corporate update on their Advanced Therapies for the Human...
FFF Enterprises Takes Top Honors in 2012 MarCom Awards Competition
November 13, 2012 09:00 ET
|
FFF Enterprises
TEMECULA, CA--(Marketwire - Nov 13, 2012) - FFF Enterprises, Inc., the nation's largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals and publisher...
Stellar Biotechnologies Presented at World Congress of Marine Biotechnology
September 26, 2012 09:45 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Sep 26, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) today announced that Frank Oakes, President...
Researchers to Present Results From Two VIRxSYS HIV Studies at the 6th International AIDS Society Meeting
June 28, 2011 10:06 ET
|
VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Jun 28, 2011) - VIRxSYS Corporation today announced that data from two HIV studies will be presented at the 6th International AIDS Society Conference on HIV...